Healthcare ETFs in 2026: Global iShares Fund Outpaces US-Focused Invesco Rival

In 2026, the healthcare sector is once again drawing attention from investors seeking defensive exposure amid macroeconomic turbulence. A comparison of two widely followed ETFs — the iShares Global Healthcare fund and the Invesco Health Care fund — reveals that the globally diversified vehicle has been delivering stronger returns than its US-focused counterpart. A key advantage of the iShares fund lies in its broad holdings of European and Asian pharmaceutical giants, which are benefiting from growing drug demand in emerging markets. For private investors, both products remain attractive ways to gain exposure to a sector historically resilient during recessions, though the global ETF offers superior diversification across geographic and regulatory risks.